Helferich and colleagues described an miR-1825/TBCB/TUBA4A pathway, demonstrating that the reduced expression of an upstream miRNA can lead to a reduction in TUBA4A protein expression in ALS patients [31]. This evidence concerns the gene TUBA4A and amyotrophic lateral sclerosis.